REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 19th, 2023 • Alpha Teknova, Inc. • In vitro & in vivo diagnostic substances
This Registration Rights Agreement (this “Agreement”) is made and entered into as of September 15, 2023, by and between Alpha Teknova, Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
INDEMNIFICATION AGREEMENTIndemnification Agreement • June 21st, 2021 • Alpha Teknova, Inc. • In vitro & in vivo diagnostic substances • Delaware
THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of between Alpha Teknova, Inc., a Delaware corporation (the “Company”), and (“Indemnitee”).
●] Shares ALPHA TEKNOVA, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • June 21st, 2021 • Alpha Teknova, Inc. • In vitro & in vivo diagnostic substances • New York
INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • June 4th, 2021 • Alpha Teknova, Inc. • In vitro & in vivo diagnostic substances • California
THIS INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 14th day of January, 2019, by and among Alpha Teknova, Inc., a Delaware corporation (the “Company”), each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”, and each of the holders of Common Stock listed on Schedule B, each of which is referred to in this Agreement as a “Key Holder”.
AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT (TERM LOAN) dated as of May 10, 2022 by and among ALPHA TEKNOVA, INC., and any additional borrower that hereafter becomes party hereto, each as Borrower, and collectively as Borrowers, and MIDCAP...Credit and Security Agreement • May 11th, 2022 • Alpha Teknova, Inc. • In vitro & in vivo diagnostic substances • New York
This AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT (TERM LOAN) (as the same may be amended, supplemented, restated or otherwise modified from time to time, the “Agreement”) is dated as of May 10, 2022 by and among ALPHA TEKNOVA, INC., a Delaware corporation, and each additional borrower that may hereafter be added to this Agreement (each individually as a “Borrower”, and collectively with any entities that become party hereto as Borrower and each of their successors and permitted assigns, the “Borrowers”), MIDCAP FINANCIAL TRUST, a Delaware statutory trust, individually as a Lender, and as Agent, and the financial institutions or other entities from time to time parties hereto, each as a Lender.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 19th, 2023 • Alpha Teknova, Inc. • In vitro & in vivo diagnostic substances • California
This Securities Purchase Agreement (this “Agreement”) is dated as of September 15, 2023, between Alpha Teknova, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
Alpha Teknova, Inc. COMMON STOCK SALES AGREEMENTCommon Stock Sales Agreement • March 30th, 2023 • Alpha Teknova, Inc. • In vitro & in vivo diagnostic substances • New York
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 19th, 2023 • Alpha Teknova, Inc. • In vitro & in vivo diagnostic substances • California
This Securities Purchase Agreement (this “Agreement”) is dated as of September 15, 2023, between Alpha Teknova, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
amendment No. 3 to AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT (REVOLVING LOAN)Credit and Security Agreement • August 11th, 2023 • Alpha Teknova, Inc. • In vitro & in vivo diagnostic substances • New York
This AMENDMENT NO. 3 TO Amended and Restated CREDIT AND SECURITY AGREEMENT (REVOLVING Loan) (this “Agreement”) is made as of July 13, 2023, by and among Alpha teknova, inc., a Delaware corporation (“Borrower”), MIDCAP FUNDING IV TRUST, a Delaware statutory trust, as Agent (in such capacity, together with its successors and assigns, “Agent”) and the other financial institutions or other entities from time to time parties to the Credit Agreement referenced below, each as a Lender.
LEASE AGREEMENT Hollister, CA 95023 Parcel Number 051-15-04-009-0Lease Agreement • June 4th, 2021 • Alpha Teknova, Inc. • In vitro & in vivo diagnostic substances
THIS LEASE is made and executed, in duplicate, at Hollister, California, on the date hereinafter set forth by and between Michael & Paige McCullough and TEKNOVA, a Corporation, hereinafter referred to respectively as “Lessor,” and “Lessee”, without regard to number or gender.
WAREHOUSE LEASE AGREEMENTWarehouse Lease Agreement • June 4th, 2021 • Alpha Teknova, Inc. • In vitro & in vivo diagnostic substances
This Warehouse Lease Agreement (“Lease Agreement”) shall be effective on January 1, 2021 (the “Effective Date”), and have the following terms and conditions.
LIMITED WAIVER AND amendment No. 5 to AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT (TERM LOAN)Credit and Security Agreement • March 11th, 2024 • Alpha Teknova, Inc. • In vitro & in vivo diagnostic substances
This LIMITED WAIVER AND AMENDMENT NO. 5 TO Amended and Restated CREDIT AND SECURITY AGREEMENT (term Loan) (this “Agreement”) is made as of March 8, 2024, by and among Alpha teknova, inc., a Delaware corporation (“Borrower”), MIDCAP FINANCIAL TRUST, a Delaware statutory trust, as Agent (in such capacity, together with its successors and assigns, “Agent”) and the other financial institutions or other entities from time to time parties to the Credit Agreement referenced below, each as a Lender.
LIMITED WAIVER AND AMENDMENT NO. 4 TO AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT (TERM LOAN)Credit and Security Agreement • September 19th, 2023 • Alpha Teknova, Inc. • In vitro & in vivo diagnostic substances • New York
This LIMITED WAIVER AND AMENDMENT NO. 4 TO AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT (TERM LOAN) (this “Agreement”) is made as of September 19, 2023, by and among ALPHA TEKNOVA, INC., a Delaware corporation (“Borrower”), MIDCAP FINANCIAL TRUST, a Delaware statutory trust, as Agent (in such capacity, together with its successors and assigns, “Agent”) and the other financial institutions or other entities from time to time parties to the Credit Agreement referenced below, each as a Lender.
amendment No. 2 to AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT (TERM LOAN)Credit and Security Agreement • March 30th, 2023 • Alpha Teknova, Inc. • In vitro & in vivo diagnostic substances • New York
This AMENDMENT NO. 2 TO Amended and Restated CREDIT AND SECURITY AGREEMENT (term Loan) (this “Agreement”) is made as of March 28, 2023, by and among Alpha teknova, inc., a Delaware corporation (“Borrower”), MIDCAP FINANCIAL TRUST, a Delaware statutory trust, as Agent (in such capacity, together with its successors and assigns, “Agent”) and the other financial institutions or other entities from time to time parties to the Credit Agreement referenced below, each as a Lender.
amendment No. 2 to AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT (REVOLVING LOAN)Credit and Security Agreement • March 30th, 2023 • Alpha Teknova, Inc. • In vitro & in vivo diagnostic substances • New York
This AMENDMENT NO. 2 TO Amended and Restated CREDIT AND SECURITY AGREEMENT (REVOLVING Loan) (this “Agreement”) is made as of March 28, 2023, by and among Alpha teknova, inc., a Delaware corporation (“Borrower”), MIDCAP FUNDING IV TRUST, a Delaware statutory trust, as Agent (in such capacity, together with its successors and assigns, “Agent”) and the other financial institutions or other entities from time to time parties to the Credit Agreement referenced below, each as a Lender.
ALPHA TEKNOVA, INC. January 14, 2019Alpha Teknova, Inc. • June 4th, 2021 • In vitro & in vivo diagnostic substances • California
Alpha Teknova, Inc., a Delaware corporation (the “Company”), is pleased to confirm the new terms of your employment with the Company as described below, subject to and effective as of the closing of the Series A Preferred Stock investment and common stock repurchase (collectively, the “Transactions”). In the event the Transactions are not otherwise consummated, the offer extended in this letter and this letter agreement shall be null and void.
FIRST AMENDMENT TO LEASE AGREEMENTLease Agreement • March 30th, 2023 • Alpha Teknova, Inc. • In vitro & in vivo diagnostic substances
This FIRST AMENDMENT TO LEASE AGREEMENT (“Amendment”), dated as of the 1st day of December, 2022 (for purposes of this Amendment, the “Effective Date”), is entered into between Ken & Jill Gimelli, LLC, a California limited liability company (“Lessor”) and Alpha Teknova, Inc., a Delaware corporation (“Lessee” and, together with Lessor, collectively referred to herein as the “Parties”).
LIMITED WAIVER AND AMENDMENT NO. 4 TO AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT (REVOLVING LOAN)Credit and Security Agreement • September 19th, 2023 • Alpha Teknova, Inc. • In vitro & in vivo diagnostic substances • New York
This LIMITED WAIVER AND AMENDMENT NO. 4 TO AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT (REVOLVING LOAN) (this “Agreement”) is made as of September 19, 2023, by and among ALPHA TEKNOVA, INC., a Delaware corporation (“Borrower”), MIDCAP FUNDING IV TRUST, a Delaware statutory trust, as Agent (in such capacity, together with its successors and assigns, “Agent”) and the other financial institutions or other entities from time to time parties to the Credit Agreement referenced below, each as a Lender.
LIMITED WAIVER AND amendment No. 5 to AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT (REVOLVING LOAN)Credit and Security Agreement • March 11th, 2024 • Alpha Teknova, Inc. • In vitro & in vivo diagnostic substances • New York
This LIMITED WAIVER AND AMENDMENT NO. 5 TO Amended and Restated CREDIT AND SECURITY AGREEMENT (REVOLVING Loan) (this “Agreement”) is made as of March 8, 2024, by and among Alpha teknova, inc., a Delaware corporation (“Borrower”), MIDCAP FUNDING IV TRUST, a Delaware statutory trust, as Agent (in such capacity, together with its successors and assigns, “Agent”) and the other financial institutions or other entities from time to time parties to the Credit Agreement referenced below, each as a Lender.
ContractStock Option Agreement • June 4th, 2021 • Alpha Teknova, Inc. • In vitro & in vivo diagnostic substances • Delaware
THE SECURITIES WHICH ARE THE SUBJECT OF THIS AGREEMENT HAVE NOT BEEN QUALIFIED WITH THE COMMISSIONER OF CORPORATIONS OF THE STATE OF CALIFORNIA AND THE ISSUANCE OF SUCH SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION THEREFOR PRIOR TO SUCH QUALIFICATION IS UNLAWFUL, UNLESS THE SALE OF SECURITIES IS EXEMPT FROM QUALIFICATION BY SECTION 25100, 25102, OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON SUCH QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.
COMMERCIAL LEASE AGREEMENTCommercial Lease Agreement • June 4th, 2021 • Alpha Teknova, Inc. • In vitro & in vivo diagnostic substances
THIS LEASE is entered into on October 7th, 2020 (the “Effective Date”), by and between Ken & Jill Gimelli, LLC, a California limited liability company (“Lessor”) and Alpha Teknova, Inc., a Delaware corporation (“Lessee”).
ALPHA TEKNOVA, INC. January 14, 2019Alpha Teknova, Inc. • June 4th, 2021 • In vitro & in vivo diagnostic substances • California
Alpha Teknova, Inc., a Delaware corporation (the “Company”), is pleased to confirm the new terms of your employment with the Company as described below, subject to and effective as of the closing of the Series A Preferred Stock investment and common stock repurchase (collectively, the “Transactions”). In the event the Transactions are not otherwise consummated, the offer extended in this letter and this letter agreement shall be null and void.
LEASELease • June 4th, 2021 • Alpha Teknova, Inc. • In vitro & in vivo diagnostic substances • Massachusetts
THIS LEASE made as of the 1st day of September, 2019 between MEECHES LLC, a Massachusetts limited liability company, of 170 Forbes Blvd., Mansfield, MA 02048 (“Lessor”), and ALPHA TEKNOVA, INC., a Delaware corporation (d/b/a Teknova), of 2290 Bert Dr. Hollister, CA 95023 (“Lessee”).
STOCK OPTION AGREEMENT ALPHA TEKNOVA, INC.Stock Option Agreement • June 4th, 2021 • Alpha Teknova, Inc. • In vitro & in vivo diagnostic substances
This Stock Option Agreement (“Agreement”) is entered into effective , 20 , by and between Alpha Teknova, Inc., a California corporation (“Company”), and Optionee (see below). Unless otherwise defined herein, all terms used in this Option Agreement shall have the same defined meanings as set forth in the 2016 Stock Plan (“Plan”), a copy of which is attached as Exhibit A.
